Ibu-Lysin - 1 A Pharma

Ibuprofen, the active ingredient in Ibu-Lysin, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is used to relieve pain, reduce fever, and diminish inflammation associated with conditions such as arthritis in adults and, when appropriate, in pediatric patients.

GNH USA supplies Ibu-Lysin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers through established distribution networks.

Ibuprofen acts on the cyclooxygenase pathway to alleviate symptoms in several common conditions.

Pain: Reduces mild to moderate pain. Fever: Lowers elevated body temperature. Inflammation: Decreases swelling and redness. Arthritis: Improves joint mobility and reduces chronic inflammation.

Ibuprofen may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate headache. - Dizziness: transient feeling of light‑headedness. - Rash: mild skin irritation or itching.

Serious or Rare Side Effects: - Gastrointestinal bleeding: ulceration or hemorrhage in the stomach or intestines. - Renal impairment: reduced kidney function or acute kidney injury. - Severe allergic reaction: anaphylaxis, swelling of face or throat.

When using ibuprofen, certain precautions should be observed to minimize risk.

Assess renal function: avoid use in patients with severe kidney disease. Monitor cardiovascular risk: use cautiously in individuals with heart disease or hypertension. Avoid concurrent NSAIDs: do not combine with other non‑steroidal anti‑inflammatory drugs. Limit alcohol intake: excessive alcohol may increase gastrointestinal toxicity. Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Ibuprofen can interact with several medicines, altering their effectiveness or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce antihypertensive effect and impair renal function. - Lithium: ibuprofen can raise lithium levels, requiring monitoring. - Methotrexate: reduced clearance may increase toxicity.